 |  |
| Health and Pharmaceuticals |
|
back to headlinesprint storyemail story 07/29/2010 05:09:09 PM EDT -- Business Wire Inhibitex to Host Conference Call to Report Second Quarter Financial Results on August 10, 2010
ATLANTA--(BUSINESS WIRE)--
Inhibitex, Inc. (NASDAQ: INHX) announced today that it will host a
conference call on Tuesday, August 10, 2010 at 9:00 a.m. EDT to review
the Company’s second quarter financial results and provide an update on
recent corporate developments. The Company will issue a press release
regarding its financial results on the same day, prior to the conference
call.
Webcast Information
To access the conference call, please dial (877) 407-9210 (domestic) or
(201) 689-8049 (international). A replay of the call will be available
from 11:00 a.m. Eastern Time on August 11th until September
10, 2010 at midnight. To access the replay, please dial (877) 660-6853
(domestic) or (201) 612-7415 (international) and reference the account #
286 and the conference id # 354732. A live audio webcast of the call and
the archived webcast will be available in the News and Events section of
the Inhibitex website at http://www.inhibitex.com.
About Inhibitex
Inhibitex, Inc., headquartered in Alpharetta, Georgia, is a
biopharmaceutical company focused on developing products to prevent and
treat serious infectious diseases. The Company’s pipeline includes
FV-100, which is in Phase II clinical development for the treatment of
shingles, and INX-189, a nucleotide polymerase inhibitor in development
for the treatment of chronic hepatitis C infections. The Company also
has additional HCV nucleotide polymerase inhibitors in preclinical
development and has licensed the use of its proprietary MSCRAMM®
protein platform to Pfizer for the development of staphylococcal
vaccines.
For additional information about the Company, please visit www.inhibitex.com.
Inhibitex, Inc. Source: Inhibitex, Inc. Copyright Business Wire 2010 |
Copyright © 2010 Acquire Media. All rights reserved.